Ftse Mib
33.220,31
0,00%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.311,61
0,53%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gossamer Bio Inc (GOSS) Gossamer Bio Inc (GOSS) Notizie

Gossamer Bio Inc

GOSS
0,56
0,0399 (7,67%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:01EDGAR2Form 8-K - Current report
07/6/202422:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/6/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202422:01BWGossamer Bio to Provide Updated Seralutinib TORREY..
10/5/202422:30BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
07/5/202422:02EDGAR2Form 8-K - Current report
07/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:01BWGossamer Bio Announces First Quarter 2024 Financial Results..
06/5/202413:31EDGAR2Form 8-K - Current report
06/5/202413:30BWGossamer Bio and Chiesi Group Announce Transformative Global..
03/5/202414:02BWGossamer Bio Announces Publication of TORREY Phase 2 Results..
12/3/202412:31BWGossamer Bio Announces Appointment of Steven D. Nathan,..
05/3/202413:37EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
05/3/202413:31EDGAR2Form 8-K - Current report
05/3/202413:31BWGossamer Bio Announces Fourth Quarter and Full-Year 2023..
04/3/202422:02EDGAR2Form 8-K - Current report
08/1/202422:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
04/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202322:01BWGossamer Bio to Host Webcast to Discuss Latest Seralutinib..
05/12/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202323:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/12/202322:01BWGossamer Bio Announces Inducement Grant Under Nasdaq Listing..
05/12/202313:01BWGossamer Bio Appoints Bob Smith as Chief Commercial Officer
29/11/202322:01EDGAR2Form 8-K - Current report
29/11/202313:01BWGossamer Bio Announces Appointment of John Quisel, J.D.,..
27/11/202322:01EDGAR2Form 8-K - Current report
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202301:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:31EDGAR2Form 8-K - Current report
09/11/202313:31BWGossamer Bio Announces Third Quarter 2023 Financial Results..
20/10/202322:01EDGAR2Form 8-K - Current report
03/10/202322:08BWGossamer Bio Announces Addition of Rainer Zimmermann, MD, as..
07/9/202323:00EDGAR2Form 8-K - Current report
07/9/202313:44BWGossamer Bio to Present Results of TORREY FRI Sub-Study at..
29/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
28/8/202322:29EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/8/202322:01EDGAR2Form DEL AM - Delaying amendment
18/8/202314:41EDGAR2Form S-3 - Registration statement under Securities Act of..
18/8/202314:38EDGAR2Form RW - Registration Withdrawal Request
17/8/202322:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
08/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202322:01EDGAR2Form 8-K - Current report
08/8/202322:01BWGossamer Bio Announces Second Quarter 2023 Financial Results..
Apertura: 0,5911 Min: 0,5312 Max: 0,60
Chiusura: 0,5201

La tua Cronologia

NASDAQ
GOSS
Gossamer Bio
BIT
P1WO73
NLBNPIT1WO73 20240920 35
TG
JUN3
Jungheinrich
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network